The concept for Cancer Management: A Multidisciplinary Approach arose nearly10 years ago. This seventh annual edition reflects the ongoing commitment ofthe authors, editors, and publishers to rapidly disseminate to oncologists themost current information on the clinical management of cancer patients.
Each chapter in this seventh edition has been updated to keep pace with themost current diagnostic and treatment recommendations. In addition, and inaccordance with the recommendations of users of previous editions of thistreatment handbook, the common chemotherapy regimens have again beenincluded within the treatment sections of each chapter, rather than as a sepa-rate Appendix as in the fifth and previous editions. Information on biologicaltherapies, too, is now included in the treatment sections of appropriate chap-ters, rather than as a separate chapter. Again, readers tell us this reorganizationmakes the treatment guide easier to use.
The current volume also provides information on newly approved drugs, suchas gefitinib (Iressa), lonafarnib (Sarasar), pemetrexed (Alimta), flavorpiridol(cyclin-dependent kinase inhibitor), epirubicin (Ellence), citalopramhydrobromide (Celexa), oxandrolone (Oxandrin), infliximab (Remicade),troxacitabine (Troxatyl), temozolomide (Temodar), tariquidar, antithymocyteglobulin (Atgam), voriconazole (Vfend), micafungin, as well as new indica-tions for alemtuzumab (Campath), capecitabine (Xeloda), darbepoetin alfa(Aranesp), zoledronic acid (Zometa), Actiq (oral transmucosal fentanyl citrate),and rituximab (Rituxan). Reports on newer clinical trials with imatinib mesylate(Gleevec), oxaliplatin (Eloxatin), erlotinib (Tarceva), thalidomide (Thalomid),raloxifene (Evista), anastrozole (Arimidex), letrozole (Femara), and others alsoare included.
The 49 chapters, one Addendum, and 2 Appendices in the latest edition repre-sent the efforts of 120 contributors (9 of whom are new) from 60 institutions inthe United States and Canada.
Three consistent goals continue to guide our editorial policies: ■ To provide practical information for physicians who manage cancer ■ To present this information concisely, uniformly, and logically, em- phasizing the natural history of the malignancy, screening and diagno-sis, staging and prognosis, and treatment ■ To emphasize a collaborative multidisciplinary approach to patient management that involves surgical, radiation, and medical oncologists,as well as other health care professionals, working as a cohesive team As with the first six annual editions, each chapter (as appropriate) in the cur-rent volume has been authored jointly by practicing medical, surgical, andradiation oncologists. In some cases, other specialists have been asked to con-tribute their expertise to a particular chapter.
All of our contributors personally manage patients using a multidisciplinary ap-proach in their respective institutions. Thus, these chapters reflect the recom-mendations of practitioners cognizant that therapies must be based on evidence-based research directed at practical patient care in a cost-effective manner.
To write, edit, and publish a 1,000-page text in less than 6 months requires thededication of all of the authors, as well as a professional publication staff tocoordinate the technical aspects of editing and publishing. We, the authors andeditors, are indebted to the following individuals: especially Gail van Koot,senior project manager for the book; Susan Reckling, managing editor of thevolume; Jim McCarthy, Senior Vice-President/Editorial; Cara Glynn, Edito-rial Director; and Melissa Warner, President of The Oncology Group. We alsothank Andrea Bovee Caldwell, Angela Cibuls, Jeannine Coronna, ChristinaFennessey, Ed Geffner, Terri Gelfand, Lisa Katz, Andrew Nash, and StaceyCuozzo for their efforts. We extend our special thanks to Robert A. Smith, PhD,and Kim Andrews Sawyer of the American Cancer Society for their guidancein helping us to update screening guidelines.
We were able to produce this edition in such a short time frame by drawingon the oncology expertise of the editors of ONCOLOGY and Oncology NewsInternational. These periodic publications, the seventh annual edition of thisbook, and continuously updated, clinically relevant oncology information canbe accessed, at no charge, at The Oncology Group website, CancerNetwork.com.
The background of this text’s cover should look familiar to readers. It is iden-tical to that of ONCOLOGY, the flagship publication of The Oncology Group,which has provided continuing medical information to oncology professionalsfor the past 16 years and is consistently ranked as the most widely read oncol-ogy journal by an independent readership audit. This cover symbolizes theongoing commitment to oncology education of The Oncology Group and theeditors and authors of this text.
Richard Pazdur, MD
Lawrence R. Coia, MD
An affiliate of Saint Barnabas Health Care System William J. Hoskins, MD
Curtis and Elizabeth Anderson Cancer Institute Memorial Health University Medical Center Lawrence D. Wagman, MD

Source: http://smcae.kiev.ua/library/posibnik/Elektro/book_TBO.pdf

Chp383903 65.83

Feasibility of an Intensive Trial of Modern Dance for Adults with Parkinson Disease Complementary Health Practice Review The online version of this article can be found at: can be found at: Complementary Health Practice Review Additional services and information for Reprints and permission:sagepub.com/journalsPermissions.navDOI: 10.1177/1533210110383903AbstractAlthough preli


Rita Yusuf Education New York University, New York, New York 2004 Environmental Health Sciences (MolecularToxicology/Carcinogenesis) “ Oxidative and Estrogen Receptor-Mediated Events in the Transformation of Human BreastEpithelial Cells MCF-10A ”Thesis Advisor: Krystyna Frenkel, Ph.D Columbia College of Columbia University, New York, New York 1990 Stuyvesant High School, New York,

Copyright © 2010-2018 Pharmacy Drugs Pdf